Metacrine to Present Role of FXR in Treating Inflammatory Bowel Disease at Digestive Disease Week 2018
31 mai 2018 16h05 HE
|
Metacrine
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
Metacrine to Present at Jefferies 2018 Global Healthcare Conference
31 mai 2018 07h30 HE
|
Metacrine
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
The IBD/TIPP Economic Optimism Index Sets New Record for Consecutive Months in Positive Territory
08 mai 2018 10h00 HE
|
Investor's Business Daily
LOS ANGELES, May 08, 2018 (GLOBE NEWSWIRE) -- The IBD/TIPP Economic Optimism Index, a leading national poll on consumer confidence, rose 1.9 percent in May to a reading of 53.6, marking a record run...
Metacrine Broadens Management Team with Two Key Hires
17 avr. 2018 08h00 HE
|
Metacrine
SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
The IBD/TIPP Economic Optimism Index Drops for Second Straight Month but Remains in Positive Territory
03 avr. 2018 10h00 HE
|
Investor's Business Daily
LOS ANGELES, April 03, 2018 (GLOBE NEWSWIRE) -- The IBD/TIPP Economic Optimism Index, a leading national poll on consumer confidence, has entered its 19th consecutive month in positive territory....
IBD Announces Third Annual Best Mutual Fund Award Winners
19 mars 2018 09h00 HE
|
Investor's Business Daily
LOS ANGELES, March 19, 2018 (GLOBE NEWSWIRE) -- Investor’s Business Daily (IBD), a leading financial news and research organization, today announced the results of its third annual Best Mutual Funds...
IBD/TIPP Economic Optimism Index Hits 13-Year High
06 févr. 2018 10h00 HE
|
Investor's Business Daily
LOS ANGELES, Feb. 06, 2018 (GLOBE NEWSWIRE) -- The IBD/TIPP Economic Optimism Index, a leading national poll on consumer confidence, increased in February to its highest level in more than 13 years....
Filament Biosolutions Partners with Leading Canadian Academic Centers for $9.1M Project to Study Precision Nutritional Therapies for Inflammatory Bowel Disease
31 janv. 2018 08h00 HE
|
Filament BioSolutions, Inc.
NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Filament BioSolutions, Inc., a company focused on the development and commercialization of clinical nutrition therapeutics announced a collaboration with...
Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease
31 janv. 2018 07h30 HE
|
Biotagenics Inc.
TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Biotagenics Inc., a microbiome-based platform company developing novel therapeutics and diagnostics is the industrial collaborator on a $9.1 million CAD...
IBD Releases Sixth Annual Best Online Brokers Survey
29 janv. 2018 09h00 HE
|
Investor's Business Daily
LOS ANGELES, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Investor’s Business Daily (IBD), a leading financial news and research organization, today announced the results of its sixth annual investor survey of...